Page 8 - paws-and-hooves-autumn-2024

ºÚÁÏÉç

 

 

 

 

 

Page 8 - paws-and-hooves-autumn-2024
P. 8

Better therapies for



      autoimmune diseases








       Autoimmune diseases, where the body’s own             Here are some research projects
       immune system attacks cells, can lead to severe       supported by our fundraisers:
       illnesses that require intensive care and carefully
       monitored prolonged treatments. Common
       autoimmune conditions in dogs include immune-              Finding new biomarkers
       mediated haemolytic anaemia (IMHA, where red               for bespoke treatment
       blood cells are damaged or destroyed by the
       immune system) and immune thrombocytopenia            Often dogs are treated according to fixed treatment
       (IMTP, where the body attacks platelets which help    protocols, but for some dogs, this isn't sufficient to control
       the blood to clot).                                   the disease or can cause excessive side effects. The ºÚÁÏÉç

       These conditions can be life-threatening and are often   is identifying new markers that can guide the treatment
       treated with blood transfusions and medications which   of individual dogs with IMHA so medication can be tailored
       suppress the immune system. In some dogs, medications   for each individual dog, to better manage their condition
       can cause side effects that negatively impact their quality   and reduce side effects.
       of life. Almost all research into canine autoimmune
       diseases is conducted in large specialist veterinary       ImmunoBank stores samples
       hospitals. However, many dogs are diagnosed and treated    for future research
       in local first-opinion veterinary practices, which means
       current information may not reflect real-world trends.    The ºÚÁÏÉç has created a bank of biological samples
       To address the shortage of information, ºÚÁÏÉç researchers   by collecting surplus blood, urine and stool samples
       are seeking additional data from first opinion practices   from dogs with autoimmune diseases like IMHA, IMTP,
       whilst exploring better therapies for this family of diseases.  immune mediated polyarthritis (IMPA) and steroid
                                                             responsive meningitis (SRMA). When pets have tests,
          Dr Barbara Glanemann, Associate Professor in       often some of the sample is left over and would normally
          Small Animal Internal Medicine:                    be thrown away but instead, with the owner’s consent,
                                                             these samples can be saved for research to improve the
                 IMHA is a devasting                         diagnosis and treatment of dogs with the same disease.
          disease that can take loved                             Establishing a fund for

          ones so quickly.                                         the future


                                                             New ideas and questions constantly arise in IMHA
        Dr Barbara Glanemann                                 treatment. This dedicated fund generated by our IMHA
                                                             fundraisers enables ºÚÁÏÉç researchers to create small
                                                             research projects to start to address these. This flexibility
                                                             enables novel project ideas to be developed which can
                                                             be expanded to larger studies if they appear promising.
                                                             One such project which benefitted from this fund, was
                                                             the development of RNA sequencing using blood cells
                                                             from dogs with IMHA. RNA is made by copying DNA
                                                             code and enables cells to follow instructions in their
                                                             genes (i.e. their genetic code). By studying this, we can
                                                             see which genes are being expressed appropriately and
                                                             inappropriately in a cell at any one time. It’s hoped RNA
                                                             sequencing will identify the reasons why IMHA develops
                                                             and progresses. Preliminary work was possible due to
                                                             our fundraisers and helped obtain further funding to
                                                             understand the development and progression of the
                                                             disease on a larger scale.
       8 8
   3   4   5   6   7   8   9   10   11   12   13